Michael W. Kalb - Executive Vice President & CFO at Catalyst Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President & CFO
Stock Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael W. Kalb since 12/5/2024

Holdings reported by Michael W. Kalb for Catalyst Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 640K $1.91M $4.01 Nov 21, 2025 Direct Common Stock
Common Stock, par value $0.001 per share 8.61K $184K $21.43 Nov 21, 2025 Direct
Options to purchase common stock 607K Nov 20, 2025 Direct Common Stock

Transactions reported by Michael W. Kalb for Catalyst Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.